Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.
Group Behavior and Emergence of Cancer Drug Resistance.
Prognostic Role of Biologically Active Volume of Disease in Patients With Metastatic Lung Adenocarcinoma.
Exploring the potential of TGFß as a diagnostic marker and therapeutic target against cancer.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Exploring the potential of TGFß as a diagnostic marker and therapeutic target against cancer.
Exploring the potential of TGFß as a diagnostic marker and therapeutic target against cancer. Biochem Pharmacol. 2025 01; 231:116646.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Biomarkers, Tumor
Epithelial-Mesenchymal Transition
Humans
Molecular Targeted Therapy
Neoplasms
Signal Transduction
Transforming Growth Factor beta
authors with profiles
Ravi Salgia